TRT + Foundational Hormone Optimization for Men Over 35
Testosterone replacement therapy for men over 35 fails when treated as monotherapy. TRT hormone optimization requires simultaneous management of thyroid function, estrogen conversion, DHT activity, insulin sensitivity, and hypothalamic-pituitary feedback. A 150 mg weekly testosterone enanthate protocol without aromatase modulation, thyroid support, or metabolic monitoring delivers suboptimal results in 60-70% of users within 12 months. … Read more